2023 annual financial data
ARS Pharmaceuticals 2023 Operating margin
ARS Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -225,066.67%.
Operating income was -67,520,000 USD and net income was -54,365,000 USD.
Operating cash flow was -59,266,000 USD.
Get free ARS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,000 USD
- Operating income
- -67,520,000 USD
- Net income
- -54,365,000 USD
- Operating cash flow
- -59,266,000 USD